CLEXANE إسرائيل - الإنجليزية - Ministry of Health

clexane

sanofi israel ltd - enoxaparin sodium - solution for injection - enoxaparin sodium 100 mg/ml ml - enoxaparin - enoxaparin - clexane is indicated in adults for: • prophylaxis of venous thromboembolic disease in moderate and high risk surgical patients, in particular those undergoing orthopaedic or general surgery including cancer surgery. • prophylaxis of venous thromboembolic disease in medical patients with an acute illness (such as acute heart failure, respiratory insufficiency, severe infections or rheumatic diseases) and reduced mobility at increased risk of venous thromboembolism. • treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe), excluding pe likely to require thrombolytic therapy or surgery. • prevention of thrombus formation in extra corporeal circulation during haemodialysis. • acute coronary syndrome: - treatment of unstable angina and non st-segment elevation myocardial infarction (nstemi), in combination with oral acetylsalicylic acid. - treatment of acute st-segment elevation myocardial infarction (stemi) including patients to be managed medically or with subsequent percutaneous coronary intervention (pci).

TRITACE COMP 2.5 MG12.5 MG إسرائيل - الإنجليزية - Ministry of Health

tritace comp 2.5 mg12.5 mg

sanofi israel ltd - hydrochlorothiazide; ramipril - tablets - ramipril 2.5 mg; hydrochlorothiazide 12.5 mg - ramipril and diuretics - ramipril and diuretics - essential hypertension.tritace comp is indicated in patients whose blood pressure cannot be adequately lowered with ramipril alone or hydrochlorothiazide alone.

TRITACE COMP 5 MG25 MG إسرائيل - الإنجليزية - Ministry of Health

tritace comp 5 mg25 mg

sanofi israel ltd - hydrochlorothiazide; ramipril - tablets - ramipril 5 mg; hydrochlorothiazide 25 mg - ramipril and diuretics - ramipril and diuretics - essential hypertension.tritace comp is indicated in patients whose blood pressure cannot be adequately lowered with ramipril alone or hydrochlorothiazide alone.

IMOVANE إسرائيل - الإنجليزية - Ministry of Health

imovane

sanofi israel ltd - zopiclone - film coated tablets - zopiclone 7.5 mg - zopiclone - zopiclone - imovane is indicated for the short-term treatment of insomnia in adults

AMBIEN CR 6.25 MG إسرائيل - الإنجليزية - Ministry of Health

ambien cr 6.25 mg

sanofi israel ltd - zolpidem tartrate - tablets extended release - zolpidem tartrate 6.25 mg - zolpidem - zolpidem - for the treatment of insomnia, characterized by difficulties with sleep onset and/or sleep maintenance (as measured by wake time after sleep onset).

AMBIEN CR 12.5 MG إسرائيل - الإنجليزية - Ministry of Health

ambien cr 12.5 mg

sanofi israel ltd - zolpidem tartrate - tablets extended release - zolpidem tartrate 12.5 mg - zolpidem - zolpidem - for the treatment of insomnia, characterized by difficulties with sleep onset and/or sleep maintenance (as measured by wake time after sleep onset).

TARGOCID 200 MG إسرائيل - الإنجليزية - Ministry of Health

targocid 200 mg

sanofi - aventis israel ltd - teicoplanin - powder for solution for injection - teicoplanin 200 mg - teicoplanin - teicoplanin - for treatment of potentially serious gram-positive infections including those which cannot be treated with other antimicrobial drugs e.g.penicillins and cephalosporins.

FERRLECIT إسرائيل - الإنجليزية - Ministry of Health

ferrlecit

sanofi israel ltd - iron as iron iii sodium ferric glugonate compl. - solution for injection/ concentrate for solution for infusion - iron as iron iii sodium ferric glugonate compl. 62.5 mg / 5 ml - various combinations - various combinations - ferrlecit is indicated in adults and children 6 years and above.severe iron deficiency states only when oral administration has been found impossible; in cases of gastrointestinal malabsorption which rules out oral iron therapy; patients treated by dialysis getting erythropoietin.

CABLIVI إسرائيل - الإنجليزية - Ministry of Health

cablivi

sanofi israel ltd - caplacizumab - powder and solvent for solution for injection - caplacizumab 10 mg/vial - caplacizumab - cablivi is indicated for the treatment of adults and adolescents of 12 years of age and older weighing at least 40 kg experiencing an episode of acquired thrombotic thrombocytopenic purpura (attp), in conjunction with plasma exchange and immunosuppression.

MAALOX PLUS SUSPENSION إسرائيل - الإنجليزية - Ministry of Health

maalox plus suspension

sanofi - aventis israel ltd - aluminium hydroxide; magnesium hydroxide; simethicone - suspension - aluminium hydroxide 175 mg / 5 ml; magnesium hydroxide 200 mg / 5 ml; simethicone 25 mg / 5 ml - antacids with antiflatulents - antacid, antiflatulent, relief of sensation of heatburn.